The Size of the Asia Pacific Prosthetic Heart Valves Market is valued at USD 0.87 billion in 2019 and estimated to be growing at a CAGR of 14.21%, to reach USD 1.69 billion by 2024 during the forecast period 2019-2024.
A prosthetic heart valve is a device that is surgically implanted in the heart of a patient suffering from valvular heart disease. This is usually done through open-heart surgery when one of the four valves present in the heart malfunctions.
Natural heart valves become dysfunctional to a variety of pathological causes, some of them including changing lifestyles or even old age. The different types of valves have different qualities which are measured in EOA or Effective Orifice Area. While the mechanical valves are made artificially, the biological valves or tissue valves are usually produced using the valves of animals such as pigs, which undergo several biochemical changes in order to make them fit to be used in human transplantations. Porcine hearts are preferred for this because pigs have the heart most similar to the human heart and are hence the best anatomical fit.
The rise of the Prosthetic Heart Valves market is mainly driven by the demand for minimally invasive cardiovascular surgeries and the rise in the number of medical centers that have the provision to perform heart surgery. Other drivers for the market include the high prevalence of Heart Valve Disorders (HVD), the increasing government funding for research regarding the same and raising awareness among patients about HVDs. Mechanical valves which are a major section of the market constantly require anti-coagulants to be administered as part of the treatment. This administration is life-long and is a put-off for the market. This along with high costs of treatment serve as the major restraints for the market growth.
Asia Pacific Prosthetic Heart Valves Market segmented and sub-segmented into the following categories.
Asia-Pacific is expected to grow rapidly in the coming years as is evident from the high CAGR value for the region. In addition to being the fastest-growing market, the region also has the third-highest market share only behind the likes in North America and Europe.
The high growth rate of the region can be attributed to the developing economies of China and India and the scope for research in the region. It is also much easier for new companies to enter the market in the region.
Noteworthy Companies leading the Asia pacific Prosthetic Heart Valves Market are Corvia Medical, CardioKinetix, Biomerics LLC, Lepu Medical Technology, XELTIS BV, Comed BV, HLT, Meril Life Sciences, SYMETIS SA and Transcatheter Technologies GmbH.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type
5.1.1 Introduction
5.1.2 Mechanical Heart Valve
5.1.3 Tissue Heart Valve
5.1.4 Transcatheter Heart Valve
5.1.5 Y-o-Y Growth Analysis, By Type
5.1.6 Market Attractiveness Analysis, By Type
5.1.7 Market Share Analysis, By Type
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Type
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Type
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Type
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Corvia Medical
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 CardioKinetix
8.3 Biomerics LLC
8.4 Lepu Medical Technology
8.5 XELTIS BV
8.6 Comed BV
8.7 Meril Life Sciences
8.8 SYSMETIS SA
8.9 HLT
8.10 Transcatheter Technologies GmbH
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
